Tarsus Pharmaceuticals Market Sentiment

Tarsus Pharmaceuticals Inc

TARSNASDAQ

Trade with Public

$74.40

1.241.69%

概要ニュース業績予想イベント目標株価財務センチメント株主構成比較オプション株式レポート

Tarsus Pharmaceuticals Market Sentiment

Market sentiment signals for Tarsus Pharmaceuticals (TARS): analyst consensus, short interest, options flow and insider activity.

Key Signals

Analyst Consensus▲ Buy

Short Interest▲ 13.4% short float

Options Flow— N/A

Insider Activity▼ Net Seller (30d)

Analyst Consensus

Buy

11 analysts

Options Flow (P/C)

—

Avg Consensus PT

$89

+19.7%

Highest Price Target

$116

+55.9%

Goldman Sachs

Lowest Price Target

$51

-31.5%

Goldman Sachs

Short Interest

13.4%

Declining — Bullish

Insider Activity (30d)

Net Seller

Short Interest — % of Float

Recent Analyst Actions

Date	Firm	Analyst & Accuracy	Upside / Downside	PT Change	Action	Rating
Sep 24, 2026	Goldman Sachs	Andrea Newkirk—	+55.9%	$116	Reinstates	Buy
Sep 16, 2026	Barclays	Glen Santangelo—	+47.8%	$110	Reinstates	Overweight
Sep 8, 2026	Jefferies	Anthony Petrone—	+41.1%	$88 → $105	Maintained	Buy
Aug 12, 2026	Oppenheimer	Francois Brisebois—	+34.4%	$97 → $100	Maintained	Outperform
Jul 31, 2026	Mizuho	Graig Suvannavejh—	+31.7%	$100 → $98	Maintained	Outperform
Jul 21, 2026	Guggenheim	Brad Canino—	+19.6%	$90 → $89	Maintained	Buy
Jul 9, 2026	HC Wainwright & Co.	Matthew Caufield—	+18.3%	$88 → $88	Maintained	Buy
May 4, 2026	HC Wainwright & Co.	Matthew Caufield—	+18.3%	$88 → $88	Maintained	Buy
Feb 25, 2026	Oppenheimer	Francois Brisebois—	+41.1%	$95 → $105	Maintained	Outperform
Feb 25, 2026	Guggenheim	Eddie Hickman—	+21.0%	$87 → $90	Maintained	Buy
Dec 9, 2025	Barclays	Glen Santangelo—	+34.4%	$100	Initiate	Overweight
Nov 20, 2025	Mizuho	Graig Suvannavejh—	+34.4%	$100	Initiate	Outperform
Nov 5, 2025	Guggenheim	Eddie Hickman—	+16.9%	$84 → $87	Maintained	Buy
Oct 20, 2025	HC Wainwright & Co.	Matthew Caufield—	+18.3%	$72 → $88	Maintained	Buy
May 27, 2025	HC Wainwright & Co.	Matthew Caufield—	-3.2%	$72	Assumes	Buy
May 5, 2025	Goldman Sachs	Andrea Tan—	-31.5%	$46 → $51	Maintained	Neutral
May 2, 2025	Guggenheim	Eddie Hickman—	+12.9%	$78 → $84	Maintained	Buy
Mar 6, 2025	Jefferies	Anthony Petrone—	-22.0%	$54 → $58	Maintained	Buy
Feb 26, 2025	Guggenheim	Eddie Hickman—	+4.8%	$75 → $78	Maintained	Buy
Feb 26, 2025	HC Wainwright & Co.	Oren Livnat—	-1.9%	$73 → $73	Maintained	Buy
Feb 26, 2025	Barclays	Balaji Prasad—	-19.4%	$62 → $60	Maintained	Overweight
Feb 24, 2025	Guggenheim	Eddie Hickman—	—	—	Maintained	Buy
Feb 10, 2025	Guggenheim	Eddie Hickman—	—	—	Maintained	Buy
Jan 27, 2025	Barclays	Balaji Prasad—	-16.7%	$60 → $62	Maintained	Overweight
Jan 22, 2025	Oppenheimer	Francois Brisebois—	-3.2%	$65 → $72	Maintained	Outperform